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Radiation Exposure for Catheterization
ariability in Fluoroscopic X-Ray Exposure in
ontemporary Cardiac Catheterization Laboratories
arren K. Laskey, MD, FSCAI, FACC,* Merrill Wondrow, BA,†
avid R. Holmes, JR, MD, FSCAI, FACC‡
lbuquerque, New Mexico; Waukesha, Wisconsin; and Rochester, Minnesota
OBJECTIVES This study sought to assess fluoroscopic exposure rates in contemporary cardiac catheteriza-
tion laboratories (CCL).
BACKGROUND Increasing attention is being focused on X-ray exposure during diagnostic and therapeutic
cardiovascular procedures.
METHODS We measured fluoroscopic exposure rates (R/min) in 41 systems using a standardized
methodology (National Electrical Manufacturers Association XR21 phantom). Measure-
ments were obtained at 2 different phantom thicknesses to simulate varying patient body
habitus.
RESULTS Fluoroscopic exposure rates under medium (median 3.0 R/min, interquartile range 1.4
R/min) and large (median 12.5 R/min, interquartile range 4.8 R/min) habitus conditions
showed substantial variation. Fluoroscopic exposure was associated with simulated patient
habitus, X-ray system type, vendor, and geographic region. Under medium habitus condi-
tions, only 25% of systems operated within a zone of lower than average exposure rates and
satisfactory image quality; this frequency diminished to 7% under large habitus conditions
(p  0.001).
CONCLUSIONS There is substantial variation (4- to 6-fold) in fluoroscopic exposure rates. This variation was
not consistently associated with improved image quality. In the absence of a predictable
benefit of higher (or lower) than average exposure rates, CCL quality improvement programs
must minimize such potentially harmful variability in X-ray exposure. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.0512006;48:1361–4) © 2006 by the American College of Cardiology Foundation
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rhe X-ray exposure levels in the cardiac catheterization
aboratory (CCL) are consistently among the highest en-
ountered in medical imaging (1). Although patient-,
rocedural- and operator-specific factors contribute to
-ray exposure in the CCL (2,3), the X-ray generating
ystem itself plays a fundamental role in determining radi-
tion exposure in the CCL (4). A general operating prin-
iple in all CCLs is to keep exposure to patients and staff as
ow as reasonably achievable (ALARA) to maintain optimal
mage quality (5).
Given the explosive growth in diagnostic and therapeutic
ardiovascular procedures, image quality and radiation ex-
osure are critical parameters that mandate periodic re-
valuation (6,7). To date, these efforts have been hampered
y a lack of standardization of measurement conditions and
he absence of an acceptable measurement tool. The pur-
From the *Division of Cardiology, University of New Mexico School of Medicine,
lbuquerque, New Mexico; †Clarte Imaging Solutions, Inc., Waukesha, Wisconsin;
nd the ‡Division of Cardiology, Department of Medicine, Mayo Clinic, Rochester,
innesota. Mr. Wondrow serves as President for Clarte Imaging Solutions, Inc. and
s a consultant to the Society for Cardiovascular Angiography and Interventions. Dr.
askey and Mr. Wondrow served as consultants to the National Electrical Manufac-
urers Association during the development of the NEMA phantom. Funding for this
ork was provided in part by the Robert S. Flinn Endowment for Cardiovascular
edicine (University of New Mexico School of Medicine).t
Manuscript received March 28, 2006; revised manuscript received May 25, 2006,
ccepted June 6, 2006.ose of the present study was to analyze fluoroscopic
xposure in a sample of CCLs using a recently developed
tandardized technique.
ETHODS
wenty high-volume CCL facilities (41 individual X-ray
ystems) voluntarily requested a vendor-independent assess-
ent of image quality. All testing was performed from May
002 to September 2005 by a vendor-independent testing
ervice (Clarte Imaging Solutions, Inc., Elk Grove, California).
hese 41 systems (25 with image intensifier detectors and 16
ith flat panel detectors) were composed of equal numbers
f academic- and community-based institutions across the
.S. The systems ranged in age from 2 to 18 years.
ational Electrical Manufactures Association (NEMA)
R 21 phantom. The development of the NEMA fluoro-
copic phantom and its implementation represent the con-
oined efforts of multiple X-ray vendors, radiation physicists,
nd experienced clinicians (8,9). Consensus among the
evelopers of the phantom allowed for thicknesses of 20 cm
nd 30 cm of Plexiglas to approximate the X-ray absorption
haracteristics of medium and heavy adult body habitus,
espectively.
Examinations were performed by a trained, certified
echnologist not affiliated with the requesting institution in
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Radiation Exposure in Catheterization Laboratories October 3, 2006:1361–4ccordance with the SCAI (Society for Cardiovascular
urgery and Interventions)/NEMA protocol (9). The out-
uts of the test determinations were entered into a confi-
ential proprietary database. Vendor and facility identifica-
ion remained anonymous.
The X-ray exposure rate (R/min) was measured at a
tandardized position 25 mm in front of the entrance
urface to the phantom using an ionization chamber dosim-
ter (model 2025, RadCal Corporation, Monrovia, Califor-
ia). Exposure rates were assessed with the X-ray system
unctioning under the usual working conditions for that
aboratory (e.g., automatic brightness control, pulsed fluo-
oscopy, temporal and spatial filtering, etc). All determina-
ions were performed in the 6- to 7-inch magnification
ode for image intensifier systems or comparable degrees
f magnification for flat detector systems.
isk-benefit analysis. Fluoroscopic exposure rate (a mea-
ure of risk) and line pair (lp) resolution (lp/mm, a measure
f image quality, or benefit) were plotted in the X-Y plane
or each system. Using median exposure rate and a line pair
esolution of 2.2 lp/mm (average value for this magnifica-
ion mode) as cut points, the bivariate scattergram could be
ivided into discrete quadrants. Thus, under medium pa-
ient habitus simulation, Quadrant I includes those systems
ith exposure rates3.0 R/min and spatial resolution2.2
p/mm. Quadrant II includes those systems with exposure
ates 3.0 R/min and spatial resolution 2.2 lp/mm.
uadrant III includes those systems with exposure rates
3.0 R/min and spatial resolution 2.2 lp/mm. Quadrant
Abbreviations and Acronyms
ALARA  as low as reasonably achievable
CCL  cardiac catheterization laboratory
IQR  interquartile range
lp  line pair
NEMA  National Electrical Manufacturers Associationigure 1. (A) Histogram of fluoroscopic exposure rates (R/min) under simulated
uoroscopic exposure rates (R/min) under simulated large habitus patient condV includes those systems with exposure rates 3.0 R/min
nd spatial resolution 2.2 lp/mm.
tatistical analysis. Dosimetric data are summarized as
edians and interquartile (25th to 75th) ranges (IQR).
xposure rates under medium versus large habitus condi-
ions and flat panel versus image intensifier systems were
ompared with rank sum statistics. Analysis of variance was
sed to assess the influence of system age, type (image
ntensifier vs. flat panel), vendor, and geographic location on
xposure rate. Contingency table analysis for matched pairs
as used in the analysis of the proportion of facilities in each
uadrant of the risk-benefit plane. All analyses were per-
ormed using Statview version 5.0 (SAS Institute Inc., Cary,
orth Carolina). A p value  0.05 was considered statisti-
ally significant.
ESULTS
luoroscopic radiation exposure. Exposure rates under
imulated medium habitus patient conditions ranged from
1 R/min to 6.5 R/min, with a median exposure of 3.0
/min (IQR 1.4 R/min). Twenty-five percent of systems
ad fluoroscopic exposure rates 3.7 R/min, whereas 25%
ad exposure rates 2.3 R/min (Fig. 1A).
Exposure rates under simulated large habitus conditions
anged from 4.4 R/min to 16.1 R/min, with a median
xposure of 12.5 R/min (IQR 4.8 R/min). These rates
ignificantly exceeded those under medium habitus patient
onditions (p  0.001). Twenty-five percent of systems had
uoroscopic exposure rates 14.0 R/min under large hab-
tus conditions (Fig. 1B).
ources of variability in fluoroscopic exposure rate. Un-
er medium habitus patient conditions, there was no asso-
iation between fluoroscopic exposure rate and the type of
etector or age of the system. There was a significant
ssociation between exposure rate and geographic locale
p  0.01) and a non-statistically significant association
etween exposure rate and system vendor (p  0.14).medium habitus patient conditions (20-cm Plexiglas). (B) Histogram of
itions (30-cm Plexiglas).
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October 3, 2006:1361–4 Radiation Exposure in Catheterization LaboratoriesExposure rates under large habitus conditions were
reater for flat panel detectors than for traditional image
ntensifiers (median values 13.8 and 9.5, respectively; p 
.001). Under large habitus conditions, there was a non-
tatistically significant association between the system age
p  0.17) and geographic locale (p  0.08) and a signifi-
ant association with vendor (p  0.02).
isk-benefit considerations and ALARA. Under me-
ium habitus conditions, there were 10 systems (25%) with
atisfactory image quality obtained at low exposure rates
Quadrant I) (Fig. 2A). In contrast, there were 9 systems
22%) with poor image quality obtained at higher exposure
ates (Quadrant III) (Fig. 2A). The remaining systems were
istributed between those with superior image quality, albeit
t higher exposure rates (Quadrant II, n 10) or those with
nferior image quality and below average exposure rates
Quadrant IV, n  7).
This risk-benefit analysis is dramatically affected under
arge habitus patient conditions (Fig. 2B). The number of
ptimal systems (Quadrant I) decreased to 3 (compared
ith Fig. 2A), whereas the number of suboptimal systems
Quadrant III) remained at 10. There, are, however, more
ystems in Quadrants II and IV reflecting conditions of
ither satisfactory image quality at higher exposure rates or
oor image quality at lower exposure rates (p  0. 01 for
omparison with medium habitus). Overall, the fraction of
ystems in Quadrant II and III (exposure in excess of need)
epresents a frequency of deviation from the ALARA
rinciple of 46% under medium habitus patient conditions
nd 59% under large habitus patient conditions (p  0.01).
ISCUSSION
here was significant variation in fluoroscopic exposure
ates among 41 contemporary CCL systems tested under
igure 2. (A) The relationship between exposure rate (R/min) and spa
onditions. The dark vertical and horizontal lines define the median and
uadrant III are exposing patients to excessive radiation with inferior imag
t lesser exposures. (B) The relationship between exposure rate and spa
omparison with Figure 2A, the dark vertical line defines the median expo
o an average spatial resolution of 2.2 lp/mm. The risk-benefit ratio is altere
xposures and inferior image quality.nbiased, standardized conditions. Such variability, in ad- eition to being of concern with respect to quality improve-
ent processes (10), resulted in frequent departures from
he ALARA principle. At identical levels of spatial
esolution, fluoroscopic exposure rates varied over 6-fold
nder medium patient habitus conditions. Moreover,
xposure rates were significantly higher under large
abitus conditions.
A prior survey of exposure rates among 62 independent
uoroscopic systems also noted substantial variation of
xposure rates under identical measurement conditions (11).
o similar multifacility studies have been performed in
CLs, in large part because of a lack of agreement con-
erning standardization of the data collection process. The
irtue of the NEMA phantom lies in its industry accep-
ance, its standardized application, and the ability to load
he X-ray system (simulate changes in body habitus) to
rovide clinically meaningful data. This also serves to
xplain the frequency of exposure rates greater than the
ederal regulatory limit of 10 R/min (12). The latter is
ssessed with the measurement probe in free air at a fixed
eometry. The NEMA standard measures phantom (pa-
ient) entrance exposure at a standardized position in front
f the phantom and accounts for higher readings than those
easured in free air (backscatter from the phantom now
ontributes to the total exposure). This is consistent with
he higher exposure rates noted with the 30-cm phantom
ecause the latter results in greater backscatter.
Interpretation of X-ray exposure data must be undertaken
ith an awareness of the many factors that determine overall
adiation exposure during fluoroscopic procedures. Among
hese factors are patient habitus, operator technique, proce-
ural complexity (13–15), and the X-ray system itself (16).
n a study of this limited nature we could not identify, or
uantify, the many system-specific sources of variation in
esolution (line pair [lp]/mm) under simulated medium patient habitus
ge exposure rate and spatial resolution, respectively. The X-ray systems in
lity, whereas systems in Quadrant I are obtaining improved image quality
solution under simulated large patient habitus conditions. To facilitate
ate under these latter conditions, and the dark horizontal line corresponds
pared with that in Figure 2A, with more X-ray systems operating at highertial r
avera
e qua
tial re
sure r
d comxposure rates. Among the latter are details regarding
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Radiation Exposure in Catheterization Laboratories October 3, 2006:1361–4ystem calibration, pattern of use, preventive maintenance
chedules, and so on. Differences in frame, or pulse, rates
ill result in different exposure rates when expressed in
/min. However, our findings and conclusions remained
nchanged when the exposure data were analyzed on a per
rame/pulse basis. Differences in kVp and mA, not con-
rolled for under these “real-life” conditions, likely reflect
endor-specific system calibrations and vendor-specific
eam filtration techniques. Thus, it is not surprising that
endor and geographic locale were associated with exposure
the latter can be viewed as a surrogate for vendor service).
Finally, these data suggest that in contemporary CCLs
here are frequent deviations from the ALARA principle—a
undamental tenet of radiation safety—that has direct im-
lications for patient and personnel exposure (17). Given
he increasing concern regarding patient exposures during
iagnostic and interventional fluoroscopic procedures
3,13,18), these data support renewed attention to overall
ystem performance, including exposure rates, as part of
ngoing quality improvement efforts in CCLs.
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